Simple Summary Colorectal cancer (CRC) is the third most common cancer worldwide.
Metastasis to secondary organs, such as the liver and lungs, is a key driver of CRC-related …

Background Recognizing the rapidly increasing interest and evidence in using metastasis-
directed radiotherapy (MDRT) for oligometastatic disease (OMD), ESTRO and ASTRO …

Purpose: The purpose of this study was to determine whether pulmonary oligometastases
from colorectal cancer have greater radioresistance than that of pulmonary oligometastases …

Introduction We assessed the radiosensitivity of lung metastases on the basis of primary
histologic type by using a validated gene signature and model lung metastases for the …

Background and purpose Colorectal cancer (CRC) represents one of the major leading
causes of death from cancer. Aim of the present study was to analyze outcome of …

Background There is growing evidence to support the hypothesis that radical treatment of
pulmonary oligometastatic disease with stereotactic body radiation therapy (SBRT) can …

It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy
(SBRT) for lung oligometastases. A systematic review of literature with a priori selection …

Background and purpose The radiobiological parameters for liver and lung metastases
treated with stereotactic body radiation therapy (SBRT) are poorly defined. This project …

In the United States of America, almost 150,000 people are estimated to be diagnosed with
colorectal cancer in 2020 and up to 35% of those are expected to present with …

The present study sought to evaluate the impact of the flattening filter‑free (FFF) technique in
volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety …